Activity-based costing in pharmaceutical development

Drug Development Research

Volumn 43, Issue 3, 1998, Pages 164-173

  Jørgensen, Stig ^a   Edwards, Martin ^b  

^a SANT + Bendix   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

ABC methodology; Benchmarking; Development costs

Indexed keywords

ACCOUNTING; COST; COST CONTROL; DRUG DEVELOPMENT; DRUG INDUSTRY; INFORMATION PROCESSING; MANAGEMENT; METHODOLOGY; ORGANIZATION; PROFIT; SHORT SURVEY;

EID: 0031865735     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199803)43:3<164::AID-DDR6>3.0.CO;2-H     Document Type: Short Survey

References (7)

1. Atkinson AA, Banker RD, Kaplan RS, Young, SM (1997): Management Accounting. Upper Saddle River, NJ: Prentice-Hall.
2. Berliner C, Brimson JA (1988): Cost Management for Today's Advanced Manufacturing. Boston, MA: Harvard Business School Press.
3. Cooper R, Kaplan, RS (1988): Measure costs right: Make the right decisions. Harv Business Rev 66:5.
4. Nanni AJD Jr, Dixon JR, Vollmann TE (1992): Integrated performance measurement: Management accounting to support the new manufacturing realities. J Manag Account Res 4.
5. Dhavale DG (1996): Problems with existing manufacturing performance measures. J Cost Manag 7.
6. Hemmer T (1996): On the design and choice of "modern" management accounting measures. J Manag Account Res 8.
7. Kaplan RS, Norton DP (1996): The Balanced Seorecard: Translating Strategy Into Action. Boston, MA: Harvard Business School Press.